HopeStage
Back to all studies
CompletedNCT00045903

Two CBT approaches for ongoing obsessive-compulsive symptoms

About this title

Cognitive Behavioral Therapy Plus Drug Treatment for Obsessive Compulsive Disorder

Read the official source — NCT00045903
Behavioural studyAges 18–70United StatesOCD
The study in practice

Understand this study

Who was this study for?

This study was for people with OCD. Listed age limits: 18 years to 70 years. Other eligibility criteria applied.

Listed locations
New York and 1 more locationSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateAugust 2000
Recruitment status
Completed
Enrollment listed in the registry
136
Sponsor
New York State Psychiatric Institute
Sponsor type
Research institute
Study type
Behavioral
Intervention type
Behavioural
Locations
United States
Age range
From 18 Years to 70 Years
Official registry ID
NCT00045903
Official title
Show the full official title

CBT Augmentation for SRI Pharmacotherapy in OCD

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

New York · Philadelphia

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is New York State Psychiatric Institute, a research institute.

Who was this study for?

This study was for people with OCD. Listed age limits: 18 years to 70 years. Other eligibility criteria applied.

Want to explore more studies?

Explore studies